SCHEMBL2877720

SCHEMBL2877720

CC(C)(C)C(=O)c1cc2c(c(C(=O)C(C)(C)C)c1C(=O)O)C(=O)OC21c2ccc(O)cc2Oc2cc(O)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.51
ALDH1A1 P00352 3/20 0.51
ALOX12 P18054 3/20 0.51
CYP2C9 P11712 2/20 0.51
ALOX15 P16050 2/20 0.51
BRCA1 P38398 2/20 0.51
HSD17B10 Q99714 2/20 0.51
FTO Q9C0B1 10/20 0.47
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.47
HTT P42858 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP2C19 P33261 1/20 0.47
RECQL P46063 1/20 0.47
BLM P54132 1/20 0.47
SMAD3 P84022 1/20 0.47
PRMT1 Q99873 1/20 0.47
ACE2 Q9BYF1 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3282095 0.96 HPGD (0.51) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL1986259 0.93 HPGD (0.49) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL2989053 0.89 HPGD (0.53) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL2407742 0.87 HPGD (0.52) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL2225607 0.85 HPGD (0.53) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL5711738 0.84 HPGD (0.45) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL3468980 0.82 HPGD (0.49) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL4802179 0.82 HPGD (0.51) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL1991388 0.82 FTO (0.42) HPGDALDH1A1ALOX12CYP2C9ALOX15
SCHEMBL8815694 0.80 FTO (0.44) HPGDALDH1A1ALOX12CYP2C9ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1573068-B1 HETEROCYCLIC FRET DYE CASSETTES FOR LABELING BIOLOGICAL MOLECULES AND THEIR USE IN DNA SEQUENCING GE HEALTHCARE BIO SCIENCES (US) 2010-10-20 EP disclosed
EP-1546391-A4 ENERGY TRANSFER DYES, TERMINATORS AND USE THEREOF AMERSHAM BIOSCIENCES CORP (US) 2006-01-04 EP disclosed
EP-1546125-A4 FLUORESCENT LABELING REAGENTS WITH MULTIPLE DONORS AND ACCEPTORS AMERSHAM BIOSCIENCES CORP (US) 2006-01-04 EP disclosed
EP-1573068-A4 HETEROCYCLIC FRET DYE CASSETTES FOR LABELING BIOLOGICAL MOLECULES AND THEIR USE IN DNA SEQUENCING AMERSHAM BIOSCIENCES CORP (US) 2006-01-04 EP disclosed
US-20050260593-A1 Fluorescent labeling reagents with multiple donors and acceptors GE HEALTHCARE BIO-SCIENCES CORP. 2005-11-24 US disclosed
US-20050255475-A1 Energy transfer dyes, terminators and use thereof GE HEALTHCARE BIO-SCIENCES CORP. 2005-11-17 US disclosed
EP-1573068-A1 HETEROCYCLIC FRET DYE CASSETTES FOR LABELING BIOLOGICAL MOLECULES AND THEIR USE IN DNA SEQUENCING Amersham Biosciences Corp. (US) 2005-09-14 EP disclosed
EP-1546125-A2 FLUORESCENT LABELING REAGENTS WITH MULTIPLE DONORS AND ACCEPTORS Amersham Biosciences Corp. (US) 2005-06-29 EP disclosed
EP-1546391-A2 ENERGY TRANSFER DYES, TERMINATORS AND USE THEREOF Amersham Biosciences Corp. (US) 2005-06-29 EP disclosed
US-6855503-B2 Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing AMERSHAM BIOSCIENCES CORP (US) 2005-02-15 US disclosed
WO-2004059011-A1 HETEROCYCLIC FRET DYE CASSETTES FOR LABELING BIOLOGICAL MOLECULES AND THEIR USE IN DNA SEQUENCING AMERSHAM BIOSCIENCES CORP (US) 2004-07-15 WO disclosed
US-20040126763-A1 Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing GE HEALTHCARE BIO-SCIENCES CORP. 2004-07-01 US disclosed
WO-2004029578-A2 ENERGY TRANSFER DYES, TERMINATORS AND USE THEREOF AMERSHAM BIOSCIENCES CORP (US) 2004-04-08 WO disclosed
WO-2004029579-A2 FLUORESCENT LABELING REAGENTS WITH MULTIPLE DONORS AND ACCEPTORS AMERSHAM BIOSCIENCES CORP (US) 2004-04-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050255475-A1 Energy transfer dyes, terminators and use thereof DNTT, RNGTT, POLRMT HPGD 2741/4885ALDH1A1 3197/4885ALOX12 4498/4885
US-20040126763-A1 Heterocyclic FRETdye cassettes for labeling biological molecules and their use in DNA sequencing DNTT, POLL, POLRMT HPGD 1094/4885ALDH1A1 2573/4885ALOX12 4364/4885
US-20050260593-A1 Fluorescent labeling reagents with multiple donors and acceptors GFPT1, PFAS, HLCS HPGD 2781/4885ALDH1A1 108/4885ALOX12 3468/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.